Telepathology Market : by Services (Static Telepathology, Dynamic Telepathology, Hybrid Telepathology), Application (Diagnosis, Education, Teleconsultation, Research), End-User ( Pharmaceutical & Biotechnology Firms, Hospitals, Academic Institutions, Others) and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Telepathology Market size was valued at USD 645.37 million in 2022 and is expected to reach a value of USD 1,788 million by 2029, at a CAGR of 12.15% from 2023 and 2029. Telepathology referred as practising pathology from a distance and telecommunication technology is used for facilitating the transmission of pathology image rich data between two distant locations for diagnosis, research and education. Pathology plays a very important role in identifying the characteristics and causes of the diseases in medical field. Electronic medical records also increase the administrative efficiency and reduces the medical cost. There are three modes of telepathology are static (or store-and-forward), dynamic (or real-time) and hybrid (or virtual. Static telepathology refers to the process of pre-selection and digitalisation of representative image by sender pathologist and sending it to the remote pathologist via e-mail or internet. Dynamic telepathology is most appropriate system for frozen-selection telepathology and for understaffed area. This involves transmission of microscopic slide images to recipient in real time via live communication. Whereas, hybrid pathology is combining both static and dynamic telepathology modes, a series of images that automatically stitched together in a software, compressed to a single file form and transmitted on the dynamic telepathology session start. Telepathology Market is technology-driven segment of medical field. It is an innovative digital imaging and telecommunication technology that is changing the healthcare delivery systems globally. The regional players are involving in acquisition of the pathology providers that present locally and strengthening their position in market.

Telepathology Market Key Developments:
  • For instance, in November 2016, Visiopharm A/S acquired LRI Imaging AB, a leading diagnostic digital pathology provider in Sweden to become leader in diagnostic digital pathology.
  • Similarly, in June 2016, Philips acquired an Irish digital pathology firm, PathXL and its digital pathology imaging technology. By this acquisition, Philips seeks to accelerate drive to support global medical institutions and their transition to digitalize workflows.

Telepathology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.15%

Largest Market

North America

Fastest Growing Market

Europe
Telepathology Market Dynamics

The telepathology market is driven by the technological advancements, digitalization of pathology. In addition, extended reach, cost-effectiveness of the services and quick diagnosis are expected to bolster the global telepathology market over the forecast period. Furthermore, ease of operation, increase in government funding for hospitals and growing demand for telemedicine are also expected to further boost the market growth during the forecast period. However, factors such as the high cost of devices, lack of skilled professionals, and lack of infrastructure in underdeveloped and developing countries expected to hamper the market growth over the forecast period. Moreover, monitoring of telepathology requires high amount of investment and errors in interpreting the digital data may act as restraints for the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Telepathology Market Segmentation

By Services
  • Static Telepathology
  • Dynamic Telepathology
  • Hybrid Telepathology
By Application
  • Diagnosis
  • Education
  • Teleconsultation
  • Research
By End User
  • Pharmaceutical & Biotechnology Firms
  • Hospitals
  • Academic Institutions
  • Others
By Geography
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • North America

Frequently Asked Questions

The key segments covered in the telepathology market are: by services, application, and end-users

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2.Global Telepathology Market Introduction 
2.1.Global Telepathology Market  - Taxonomy
2.2.Global Telepathology Market  - Definitions
2.2.1.Services 
2.2.2.Application
2.2.3. End-user
2.2.4.Region
3.Global Telepathology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Telepathology Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Telepathology Market  By Services , 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Static Telepathology
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Dynamic Telepathology
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hybrid Telepathology
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Telepathology Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Diagnosis
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Education
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Teleconsultation
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Research
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Telepathology Market  By  End-user, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Pharmaceutical & Biotechnology Firms
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals,
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Academic Institutions
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Telepathology Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Services  Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Static Telepathology
9.1.2.Dynamic Telepathology
9.1.3.Hybrid Telepathology
9.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Diagnosis
9.2.2.Education
9.2.3.Teleconsultation
9.2.4.Research
9.3.   End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmaceutical & Biotechnology Firms
9.3.2.Hospitals,
9.3.3.Academic Institutions
9.3.4.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Services  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Static Telepathology
10.1.2.Dynamic Telepathology
10.1.3.Hybrid Telepathology
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Diagnosis
10.2.2.Education
10.2.3.Teleconsultation
10.2.4.Research
10.3.   End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmaceutical & Biotechnology Firms
10.3.2.Hospitals,
10.3.3.Academic Institutions
10.3.4.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Services  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Static Telepathology
11.1.2.Dynamic Telepathology
11.1.3.Hybrid Telepathology
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Diagnosis
11.2.2.Education
11.2.3.Teleconsultation
11.2.4.Research
11.3.   End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmaceutical & Biotechnology Firms
11.3.2.Hospitals,
11.3.3.Academic Institutions
11.3.4.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Services  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Static Telepathology
12.1.2.Dynamic Telepathology
12.1.3.Hybrid Telepathology
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Diagnosis
12.2.2.Education
12.2.3.Teleconsultation
12.2.4.Research
12.3.   End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmaceutical & Biotechnology Firms
12.3.2.Hospitals,
12.3.3.Academic Institutions
12.3.4.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Telepathology Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Services  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Static Telepathology
13.1.2.Dynamic Telepathology
13.1.3.Hybrid Telepathology
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Diagnosis
13.2.2.Education
13.2.3.Teleconsultation
13.2.4.Research
13.3.   End-user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmaceutical & Biotechnology Firms
13.3.2.Hospitals,
13.3.3.Academic Institutions
13.3.4.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Southeastern Pathology Associates (U.S.)
14.2.2.Visiopharm A/S (Denmark)
14.2.3.Laboratory Corporation of America Holdings (LabCorp) (U.S.)
14.2.4.University Health Network (Canada)
14.2.5.Canada Health Infoway
14.2.7.Telemedicine Clinic (TMC) (Spain)
14.2.8.microDimensions (Germany)
14.2.9.AMD Global Telemedicine, Inc. (U.S.)
14.2.10.Polycom, Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Southeastern Pathology Associates (U.S.)
  • Visiopharm A/S (Denmark)
  • Laboratory Corporation of America Holdings (LabCorp) (U.S.)
  • University Health Network (Canada)
  • Canada Health Infoway
  • Telemedicine Clinic (TMC) (Spain)
  • microDimensions (Germany)
  • AMD Global Telemedicine, Inc. (U.S.)
  • Polycom, Inc. (U.S.)

Adjacent Markets